Axon Capital’s Momentus Inc Warrant MNTSW Stock Holding History

Axon Capital’s Portfolio MNTSW Stock Details MNTSW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$10.2K	Hold	500,000	–	–	0.01%	15
2025 Q4	$10.5K	Buy	+500,000	New	+$14.8K	0.01%	14
2022 Q3	$90K	Hold	500,000	–	–	0.39%	3
2022 Q2	$155K	Hold	500,000	–	–	0.37%	7
2022 Q1	$240K	Hold	500,000	–	–	0.56%	8
2021 Q4	$240K	Buy	+500,000	New	+$873K	0.38%	8

Other funds holding MNTSW

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Intellectus Partners San Francisco, California $490M AUM 35.11% 1-Year Est. Return

Jones Financial Companies Des Peres, Missouri $208B AUM 16.12% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Axon Capital's MNTSW Position: Q1 2026 in Review

Axon Capital held its Momentus Inc Warrant (MNTSW) position steady in Q1 2026 at 500,000 shares worth $10.2K. The position accounts for 0.01% of the portfolio, ranked #15.

Axon Capital first reported a position in MNTSW in Q4 2021 and has held it in 6 quarters since. The position peaked at $240K in Q1 2022. 8 funds tracked by Wall St. Rank hold MNTSW as of Q1 2026.

Axon Capital held 500,000 shares of Momentus Inc Warrant worth $10.2K as of Q1 2026.
Axon Capital left its Momentus Inc Warrant share count unchanged in Q1 2026.
Momentus Inc Warrant made up 0.01% of Axon Capital's portfolio in Q1 2026, its #15 holding.
Axon Capital first reported a position in Momentus Inc Warrant in Q4 2021 and has held it in 6 quarters since.
Axon Capital's Momentus Inc Warrant position peaked at $240K in Q1 2022.
8 funds tracked by Wall St. Rank held Momentus Inc Warrant as of Q1 2026.

Based on Axon Capital's 13F filing for Q1 2026, filed 15 May 2026.